al-01567 has been researched along with alx 1393 in 1 studies
| Studies (al-01567) | Trials (al-01567) | Recent Studies (post-2010) (al-01567) | Studies (alx 1393) | Trials (alx 1393) | Recent Studies (post-2010) (alx 1393) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 18 | 0 | 13 |
| Protein | Taxonomy | al-01567 (IC50) | alx 1393 (IC50) |
|---|---|---|---|
| Galanin receptor type 2 | Rattus norvegicus (Norway rat) | 0.0211 | |
| Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | 4 | |
| Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | 0.0753 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, H; Han, F; Hao, X; Huang, Y; Jiang, X; Liu, J; Liu, W; Yang, J; Yin, L; Zhang, H | 1 |
1 other study(ies) available for al-01567 and alx 1393
| Article | Year |
|---|---|
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
Topics: beta Catenin; Breast Neoplasms; Disease Progression; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Female; Fluorenes; Humans; Hydantoins; Serine; Transcription Factors; Wnt Signaling Pathway | 2017 |